Results 1 to 10 of about 686,514 (182)

Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d’Ivoire [PDF]

open access: yesTropical Medicine and Infectious Disease
Seasonal malaria chemoprevention (SMC) is a strategy recommended by the World Health Organization for children aged 3–59 months in the Sahel and sub-Sahel regions where malaria transmission is seasonal.
William Yavo   +2 more
exaly   +7 more sources

Optimal Dosing of Dihydroartemisinin-Piperaquine for Seasonal Malaria Chemoprevention in Young Children [PDF]

open access: yesNature Communications, 2019
Seasonal malaria chemoprevention provides substantial benefit for young children, but resistance to used drugs will likely develop. Here, Chotsiri et al.
Brian Greenwood   +2 more
exaly   +8 more sources

Parasitological efficacy of seasonal malaria chemoprevention in Nampula, northern Mozambique. [PDF]

open access: yesTrans R Soc Trop Med Hyg
Abstract Background Deployment of seasonal malaria chemoprevention (SMC) for young children using monthly sulphadoxine-pyrimethamine-amodiaquine (SPAQ) has recently been extended to Central and East Africa.
Bonnington C   +12 more
europepmc   +5 more sources

Seasonal malaria chemoprevention: successes and missed opportunities [PDF]

open access: yesMalaria Journal, 2017
Seasonal malaria chemoprevention (SMC) was recommended in 2012 for young children in the Sahel during the peak malaria transmission season. Children are given a single dose of sulfadoxine/pyrimethamine combined with a 3-day course of amodiaquine, once a ...
Matthew E. Coldiron   +2 more
doaj   +5 more sources

Combining seasonal malaria chemoprevention with novel therapeutics for malaria prevention: a mathematical modelling study. [PDF]

open access: yesPLoS Comput Biol
Abstract Vaccines, monoclonal antibodies, and long-acting injectables are being developed to prevent Plasmodium falciparum malaria. These therapeutics may target multiple stages of the parasite life cycle; evidence is needed to articulate their benefits with chemoprevention and ...
Braunack-Mayer L   +5 more
europepmc   +6 more sources

School-Aged Children Based Seasonal Malaria Chemoprevention Using Artesunate-Amodiaquine in Mali

open access: yesParasite Epidemiology and Control, 2018
Introduction: Malaria is still a public health problem in Africa. Seasonal Malaria Chemoprevention (SMC) is an efficient control strategy recommended by WHO that targets children under five year old living in areas of seasonal malaria transmission.
Mahamadou A. Thera, Abdoulaye K Kone
exaly   +4 more sources

Status and prospects of seasonal malaria chemoprevention among children in Sahelian countries: A systematic review and meta-analysis. [PDF]

open access: yesPLOS Global Public Health
In areas with seasonal malaria transmission, seasonal malaria chemoprevention (SMC) involves giving children a three-day course of sulfadoxine-pyrimethamine and amodiaquine once a month during the transmission season.
Medard Djedanem   +4 more
doaj   +3 more sources

Dihydroartemisinin-piperaquine effectiveness for seasonal malaria chemoprevention in settings with extended seasonal malaria transmission in Tanzania

open access: yesScientific Reports
Effectiveness of dihydroartemisinin-piperaquine (DP) as seasonal malaria chemoprevention (SMC) was assessed in Nanyumbu and Masasi Districts. Between March and June 2021, children aged 3–59 months were enrolled in a cluster randomized study.
Richard Mwaiswelo   +7 more
doaj   +4 more sources

Seasonal malaria chemoprevention for malaria in children in areas with seasonal malaria

open access: yes, 2022
This report was considered by the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2.3 Seasonal malaria chemoprevention (SMC)” of the WHO Guidelines for malaria, 3 June 2022.
Thwing JI   +4 more
openaire   +3 more sources

Usefulness of seasonal malaria chemoprevention in the Sahel

open access: yesThe Lancet Infectious Diseases, 2023
Seasonal malaria chemoprevention is an important intervention recommended for children aged 3–59 months living in highly seasonal transmission areas of the Sahel subregion of Africa to provide protection against malaria during the rainy season.
Nadine Kayiba, Kalenda   +6 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy